TY - JOUR
T1 - A Randomized Controlled Trial Comparing the Depth of Maximal Insertion Between Anterograde Single-Balloon Versus Spiral Enteroscopy
AU - Moran, Robert A.
AU - Barola, Sindhu
AU - Law, Joanna K.
AU - Amateau, Stuart K.
AU - Rolshud, Daniil
AU - Corless, Erin
AU - Kiswani, Vandhana
AU - Singh, Vikesh K.
AU - Kalloo, Anthony N.
AU - Khashab, Mouen A.
AU - Marie Lennon, Anne
AU - Okolo, Patrick I.
AU - Kumbhari, Vivek
N1 - Publisher Copyright:
© The Author(s) 2018.
PY - 2018/1/22
Y1 - 2018/1/22
N2 - Background: Three device-assisted deep endoscopic platforms presently exist and are available for clinical use: double-balloon enteroscopy, single-balloon enteroscopy (SBE), and spiral enteroscopy (SE). In a retrospective study, SE was associated with a greater depth of maximal insertion (DMI) with similar diagnostic yields and procedure time as compared with SBE. Aims: This was a prospective, randomized comparison of SE and SBE with respect to DMI, diagnostic yield, procedure time, and rate of adverse events. Methods: Patients were prospectively randomized to undergo either anterograde SE or SBE. Patient demographics, indication for procedure, DMI, procedure time, therapeutic procedure time, adverse event, diagnostic findings, and therapeutic interventions were prospectively recorded. The primary outcome was DMI. Secondary outcomes included: procedure time; diagnostic yield; therapeutic yield and adverse event rates. Results: During the study period, 30 patients underwent deep enteroscopy (SE 13, SBE 17). The most common indication was gastrointestinal bleeding in both groups. There was no significant difference in the DMI between SE and SBE (330.0 ± 88.2 cm vs 285.3 ± 80.8 cm, P =.16). There was no difference between SE and SBE in procedure time (37.0 ± 10.5 vs 38.3 ± 12.4, P =.76), diagnostic yield (SE = 9 [69%] vs SBE = 7 [41%], P =.16), or therapeutic yield (SE = 6 [46%] vs SBE = 4 [24%], P =.26). There were no major adverse events in either group. Conclusions: Spiral enteroscopy and SBE are similar with respect to DMI, diagnostic yield, therapeutic yield, procedure time, and rate of adverse events. Small numbers prevent giving a definitive judgment and future adequately powered prospective study is required to confirm these findings.
AB - Background: Three device-assisted deep endoscopic platforms presently exist and are available for clinical use: double-balloon enteroscopy, single-balloon enteroscopy (SBE), and spiral enteroscopy (SE). In a retrospective study, SE was associated with a greater depth of maximal insertion (DMI) with similar diagnostic yields and procedure time as compared with SBE. Aims: This was a prospective, randomized comparison of SE and SBE with respect to DMI, diagnostic yield, procedure time, and rate of adverse events. Methods: Patients were prospectively randomized to undergo either anterograde SE or SBE. Patient demographics, indication for procedure, DMI, procedure time, therapeutic procedure time, adverse event, diagnostic findings, and therapeutic interventions were prospectively recorded. The primary outcome was DMI. Secondary outcomes included: procedure time; diagnostic yield; therapeutic yield and adverse event rates. Results: During the study period, 30 patients underwent deep enteroscopy (SE 13, SBE 17). The most common indication was gastrointestinal bleeding in both groups. There was no significant difference in the DMI between SE and SBE (330.0 ± 88.2 cm vs 285.3 ± 80.8 cm, P =.16). There was no difference between SE and SBE in procedure time (37.0 ± 10.5 vs 38.3 ± 12.4, P =.76), diagnostic yield (SE = 9 [69%] vs SBE = 7 [41%], P =.16), or therapeutic yield (SE = 6 [46%] vs SBE = 4 [24%], P =.26). There were no major adverse events in either group. Conclusions: Spiral enteroscopy and SBE are similar with respect to DMI, diagnostic yield, therapeutic yield, procedure time, and rate of adverse events. Small numbers prevent giving a definitive judgment and future adequately powered prospective study is required to confirm these findings.
KW - Spiral
KW - balloon
KW - enteroscopy
KW - randomized control trial
KW - small bowel
UR - http://www.scopus.com/inward/record.url?scp=85055138856&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055138856&partnerID=8YFLogxK
U2 - 10.1177/1179552218754881
DO - 10.1177/1179552218754881
M3 - Article
C2 - 29398926
AN - SCOPUS:85055138856
SN - 1179-5522
VL - 11
JO - Clinical Medicine Insights: Gastroenterology
JF - Clinical Medicine Insights: Gastroenterology
ER -